Stock A053950 KYUNG NAM PHARM CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Kyung Nam Pharm Co.,Ltd.

Equities

A053950

KR7053950002

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
1,044 KRW -.--% Intraday chart for Kyung Nam Pharm Co.,Ltd. -7.45% -37.93%
2023 Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 5 billion in funding CI
2023 Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 5 billion in funding CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 5 billion in funding
CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 5 billion in funding
CI
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 5 billion in funding
CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 5 billion in funding
CI
Kyung Nam Pharm Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Kyung Nam Pharm Co.,Ltd. agreed to acquire 9.94% stake in ILYA Co., Ltd from Kang, Jae Woo and Han, Seung Ja for KRW 7 billion.
CI
Enterpartners Co., LTD announced that it expects to receive KRW 26.599899939 billion in funding from Kyung Nam Pharm Co.,Ltd.
CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 9.02379645 billion in funding from Blueberry NFT CO.,LTD.
CI
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 8 billion in funding from Metaplex Co., Ltd., and other investors
CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 8 billion in funding from Metaplex Co., Ltd., and other investors
CI
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it has received KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd.
CI
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it expects to receive KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd.
CI
Kyung Nam Pharm Co.,Ltd., Virtualtek Corp and Ventage Partners Co., Ltd. agreed to acquire 9.32% stake in Livefinancial Co.,Ltd. for KRW 5.8 billion.
CI
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 1.9999997 billion in funding from KyungNam Biopharma CO.,LTD.
CI
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 14.5 billion in funding from Kartoon Korea CO.,LTD. and other investors
CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 14.5 billion in funding from Kartoon Korea CO.,LTD. and other investors
CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 1.9999997 billion in funding from BioGenetics CO.,LTD.
CI
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 20.49998703 billion in funding from BioGenetics CO.,LTD., Liveplex Co.,Ltd., CTGen Co.,Ltd., Widwin Investment Co., Ltd.
CI
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 6.49999411 billion in funding from BioGenetics CO.,LTD.
CI
BioGenetics CO.,LTD. acquired additional unknown stake in Kyung Nam Pharm Co.,Ltd. for KRW 22.5 billion.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A053950 Stock
  4. News Kyung Nam Pharm Co.,Ltd.